Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI
Prostate Cancer, Multiparametric MRI
About this trial
This is an interventional diagnostic trial for Prostate Cancer
Eligibility Criteria
Inclusion Criteria: Clinical suspicion of prostate cancer (PSA >4 ng/ml or suspicious digital rectal exam/transrectal ultrasound) Exclusion Criteria: General contraindications for MRI (cardiac pacemakers, neurostimulators, ferric metal) or gadolinium based contrast agents (GFR <30 ml/min/1.73 m2, prior severe allergic reactions) Severe claustrophobia
Sites / Locations
- University Hospital Bonn
Arms of the Study
Arm 1
Experimental
Deep learning based reconstruction of T2-TSE sequence
Participants undergo multiparametric MRI of the prostate with inclusion of standard cartesian T2-TSE and non-cartesian T2-weighted sequences, as well as a newly developed deep learning enhanced T2-TSE sequence. All patients in this study undergo the same imaging protocol.